Binance founder Changpeng ‘CZ’ Zhao has signed a memorandum of understanding (MoU) with the Kyrgyz Republic’s National Investment Agency (NIA) to develop the country’s cryptocurrency and blockchain ...

Sonnet BioTherapeutics Holdings (NASDAQ:SONN) today announced positive safety results from its Phase 1b/2a clinical trial (SB221) evaluating SON-1010, the Company’s proprietary fully human interleukin ...

Shares of GE Healthcare (NASDAQ:GEHC), a leading medical equipment manufacturer, fell 7.1% to $66.90 in pre-market trading on Friday following news of export restrictions from China. Beijing announced ...

Cango Inc., a publicly traded Chinese conglomerate, has finalised a $352 million deal to sell its legacy auto financing business in China to Ursalpha Digital Limited, an entity linked to Bitmain’s ...

Shares of several major U.S. pharmaceutical companies dropped in premarket trading on Friday, caught in a broader market sell-off, after President Donald Trump singled out the sector with threats of ...

In a significant advancement for breast cancer treatment, the European Commission has approved AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) as a monotherapy for adult ...

Orthocell (ASX:OCC) has received US FDA 510(k) clearance for its Remplir nerve repair product, enabling the company to enter the $1.6 billion US nerve repair market. The milestone is expected to boost ...

Nutritional Growth Solutions (ASX:NGS) has appointed Manik Pujara as its Interim CFO, effective immediately. Pujara, a Chartered Accountant and member of the Australian Institute of company directors, ...

In a dramatic turn of events, Apple (NASDAQ:AAPL) experienced its largest single-day stock decline in five years on Thursday, shedding roughly 9% of its value as investors reacted to President Donald ...

Estrella Resources (ASX:ESR) has partnered with Dili-based CoreSearch Minerals and Mining Services to establish mineral drilling operations in Timor-Leste. CoreSearch, a division of H2O Group with ...

Shares of luxury furniture retailer RH (NYSE:RH) are facing heavy selling pressure in premarket trading today, falling approximately 7% to $139. The sharp decline follows a significant downgrade from ...

Mesoblast (ASX:MSB), a leader in allogeneic cellular medicines, announced today that its allogeneic products, including Ryoncil and Revascor, are designated as 'US Country of Origin' and will not be ...